Other OTC - Delayed Quote • USD
Agile Therapeutics, Inc. (AGRX)
At close: April 24 at 3:03 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.51 | -0.31 | 0.78 | 1.1 |
Low Estimate | -0.51 | -0.31 | 0.78 | 1.1 |
High Estimate | -0.51 | -0.31 | 0.78 | 1.1 |
Year Ago EPS | -5.91 | -2.15 | -6.71 | 0.78 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 3.75M | 5.63M | 36.84M | 50.93M |
Low Estimate | 3.75M | 5.63M | 36.84M | 50.93M |
High Estimate | 3.75M | 5.63M | 36.84M | 50.93M |
Year Ago Sales | 3.4M | 5.5M | 19.59M | 36.84M |
Sales Growth (year/est) | 10.30% | 2.30% | 88.00% | 38.20% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -7.5 | -7 | -1.84 | -0.92 |
EPS Actual | -5.91 | -2.15 | -0.27 | -1.51 |
Difference | 1.59 | 4.85 | 1.57 | -0.59 |
Surprise % | 21.20% | 69.30% | 85.30% | -64.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.51 | -0.31 | 0.78 | 1.1 |
7 Days Ago | -0.51 | -0.31 | 0.78 | 1.1 |
30 Days Ago | -0.51 | -0.31 | 0.78 | 1.1 |
60 Days Ago | -0.1 | 0.09 | 0.66 | 1.66 |
90 Days Ago | -0.1 | 0.09 | 0.66 | 1.66 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | AGRX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 91.40% | -- | -- | 1.50% |
Next Qtr. | 85.60% | -- | -- | 11.40% |
Current Year | 111.60% | -- | -- | 5.20% |
Next Year | 41.00% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | Maxim Group: Buy to Hold | 3/18/2024 |
Upgrade | Maxim Group: Hold to Buy | 9/22/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 6/26/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 6/7/2023 |
Related Tickers
GHSI Guardion Health Sciences, Inc.
7.98
-1.12%
ETON Eton Pharmaceuticals, Inc.
3.2100
-2.13%
CPHI China Pharma Holdings, Inc.
0.3150
-0.76%
AKAN Akanda Corp.
0.0897
-2.39%
BFRI Biofrontera Inc.
1.6600
+10.67%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3890
+0.26%
AYTU Aytu BioPharma, Inc.
2.8000
+2.94%
YCBD cbdMD, Inc.
0.9000
-1.11%
EVOK Evoke Pharma, Inc.
0.4475
+0.90%
DERM Journey Medical Corporation
3.4000
-3.95%